Ying Chi

Oct 7, 2024 | nature.com | Rongfeng Fu |Jia Chen |Wei Liu |Yunfei Chen |Ying Chi |Xiaolei Pei | +3 more

AbstractThe paucity of essential thrombocythemia (ET) and prefibrotic primary myelofibrosis (pre-PMF) in individuals younger than 18 years highlights several unresolved issues in diagnosis, clinical outcomes, and treatment strategies. To address these knowledge gaps, we analyzed a large bidirectional cohort consisting of childhood and adolescent ET (CAA-ET, n = 156) and pre-PMF (CAA-preMF, n = 13), as well as adult ET (n = 349).